So proud of our cross-disciplinary team! Ina and Elly #WomenInScience presenting at #PSANZ2023 about our clinical trial establishing Anakinra for early life inflammatory diseases and our study on Type 2 polarization in early life cardiopulmonary disease.
Our latest review published in @IJMS_MDPI on the role of the interleukin-1 family in complications of prematurity https://t.co/FnqYt5xiCE Congratulations to the team !
@fuzzymittens Iโm a neonatologist - yesterday I was at an emergency ceaser and had an obstetrician (who knows me) look me dead in the eye and ask โif paeds are hereโ and tell me to call paeds ๐คฆ๐ผโโ๏ธ #IamPaeds
Baby Max was born at just 27 weeks. #PrematureBaby
When the opportunity arose for Max to be the first participant in a trial of a new treatment, #Anakinra, his mum Susana readily agreed.
Read more or to #Donate to our Infantsโ Health Appeal: https://t.co/gNjmMRGV5n
@NoldLab
@VicGovDH If weโve declared the pandemic over then why are you still reporting weekly cases? Why not report cases of RSV and Influenza as well? Also endemic viruses that have caused a huge problem over winter ๐คท๐ผโโ๏ธ
@cazzalou21@andrewjtagg They also go to Monash Childrenโs which admittedly gets more than metro and regional services, but still far less than the RCH
Did you know that worldwide fewer medicines are authorized for use in babies & children when compared to adults? This needs to change! For this reason, we are so excited sharing the news - we recruited our first baby into the Anakinra trial for early life inflammatory diseases.